1. Home
  2. CNTB vs KOSS Comparison

CNTB vs KOSS Comparison

Compare CNTB & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • KOSS
  • Stock Information
  • Founded
  • CNTB 2012
  • KOSS 1953
  • Country
  • CNTB United States
  • KOSS United States
  • Employees
  • CNTB N/A
  • KOSS N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • CNTB Health Care
  • KOSS Consumer Staples
  • Exchange
  • CNTB Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • CNTB 68.5M
  • KOSS 63.0M
  • IPO Year
  • CNTB 2021
  • KOSS N/A
  • Fundamental
  • Price
  • CNTB $1.17
  • KOSS $7.34
  • Analyst Decision
  • CNTB Strong Buy
  • KOSS
  • Analyst Count
  • CNTB 1
  • KOSS 0
  • Target Price
  • CNTB $8.00
  • KOSS N/A
  • AVG Volume (30 Days)
  • CNTB 24.6K
  • KOSS 183.8K
  • Earning Date
  • CNTB 09-05-2024
  • KOSS 11-08-2024
  • Dividend Yield
  • CNTB N/A
  • KOSS N/A
  • EPS Growth
  • CNTB N/A
  • KOSS N/A
  • EPS
  • CNTB N/A
  • KOSS N/A
  • Revenue
  • CNTB $24,116,000.00
  • KOSS $12,265,069.00
  • Revenue This Year
  • CNTB N/A
  • KOSS N/A
  • Revenue Next Year
  • CNTB $63.90
  • KOSS N/A
  • P/E Ratio
  • CNTB N/A
  • KOSS N/A
  • Revenue Growth
  • CNTB N/A
  • KOSS N/A
  • 52 Week Low
  • CNTB $0.68
  • KOSS $2.27
  • 52 Week High
  • CNTB $2.84
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 44.02
  • KOSS 50.17
  • Support Level
  • CNTB $1.18
  • KOSS $7.00
  • Resistance Level
  • CNTB $1.26
  • KOSS $7.83
  • Average True Range (ATR)
  • CNTB 0.07
  • KOSS 0.44
  • MACD
  • CNTB -0.01
  • KOSS -0.01
  • Stochastic Oscillator
  • CNTB 13.59
  • KOSS 32.26

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: